Learn More
Apexbio Technology LLC AZD-3463 1356962-20-3 100mg

Supplier: Apexbio Technology LLC A8620100
AZD-3463 (CAS 1356962-20-3) is an orally bioavailable small molecule inhibitor targeting anaplastic lymphoma kinase (ALK) and insulin-like growth factor 1 receptor (IGF1R) exhibiting a Ki of 0 75 nM ALK expression is predominantly neuronal and is upregulated in neuroblastoma where its activation promotes cell survival and proliferation In vitro AZD-3463 suppresses proliferation of neuroblastoma cell lines with wild-type or mutant ALK by inhibiting the ALK-mediated PI3K/AKT/mTOR signaling pathway leading to apoptosis and autophagy induction AZD-3463 also enhances the cytotoxicity of chemotherapeutic agents such as doxorubicin and temozolomide In vivo it has demonstrated efficacy in reducing neuroblastoma growth in xenograft mouse models
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.